Information for Patients

More resources on Information for Patients

• Testimony on CDER’s Risk Communication Failures, December 7, 2005
• Letter Concerning FDA-Approved Medication Guides, July 25, 2005
• Letter Concerning Misleading Patient Information on Hormone Replacement Therapy, September 26, 2003
• Opinion Editorial in the Washington Post: Food and Drug Disaster, September 10, 2003
• Testimony on the Status of Written Prescription Drug Information for Consumers, July 31, 2003
• Book Review of “Democracy By Disclosure” Published in the NEJM, May 8, 2003
• Statement: Government to Improve Patient Drug Information Program, April 7, 2003
• Public Citizen v. HHS (Challenging failure to seek public input on patient information rules), February 6, 2003
• Op-Ed in Pharmacoepidemiology and Drug Safety on Drug Safety Withdrawals, December 2002
• Testimony on Patient Drug Information, July 17, 2002
• Comments on the FDA Implementation of the Data Quality Act, June 13, 2002
• Comments on a FDA Survey on the Status of Written Prescription Drug Information for Patients, February 29, 2000